ALS dysphagia pathophysiology: Differential botulinum toxin response

Neurology

Volumn 80, Issue 7, 2013, Pages 616-620

  Restivo, Domenico A ^a   Casabona, Antonino ^b   Nicotra, Alessia ^c   Zappia, Mario ^b   Elia, Maurizio ^d   Romano, Marcello C ^e   Alfonsi, Enrico ^f   Marchese Ragona, Rosario ^g  

^a GARIBALDI HOSPITAL   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^d OASI RESEARCH INSTITUTE IRCCS   (Italy)

^e Hospital Villa Sofia   (Italy)

^f C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^g UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; RILUZOLE; MUSCLE RELAXANT AGENT;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG TOLERABILITY; DYSPHAGIA; ELECTROMYOGRAM; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PENETRATION ASPIRATION SCALE; PRIORITY JOURNAL; RATING SCALE; TREATMENT RESPONSE; UPPER ESOPHAGUS SPHINCTER; AGE; DRUG EFFECT; ELECTROMYOGRAPHY; FLUOROSCOPY; FOLLOW UP; MIDDLE AGED; NONPARAMETRIC TEST; PHARYNGEAL MUSCLE; SEVERITY OF ILLNESS INDEX; VIDEORECORDING;

AGE FACTORS; AGED; AMYOTROPHIC LATERAL SCLEROSIS; BOTULINUM TOXINS, TYPE A; DEGLUTITION DISORDERS; ELECTROMYOGRAPHY; ESOPHAGEAL SPHINCTER, UPPER; FEMALE; FLUOROSCOPY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PHARYNGEAL MUSCLES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; VIDEO RECORDING;

MLCS; MLOWN;

EID: 84875825867     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318281cc1b     Document Type: Article

References (16)

1. Leighton SE, Burton MJ, Lund WS, Cochrane GM. Swallowing in motor neurone disease. J R Soc Med 1994;87: 801-805.
2. Kühnlein P, Gdynia HJ, Sperfeld AD, et al. Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis. Nat Clin Pract Neurol 2008;4:366-374.
3. Leder SB, Novella S, Patwa H. Use of fiberoptic evaluation of swallowing (FEES) in patients with amyotrophic lateral sclerosis. Dysphagia 2004;19:177-181.
4. Restivo DA, Palmeri A, Marchese-Ragona R. Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease. N Engl J Med 2002;346:1174-1175.
5. Alfonsi E, Merlo IM, Ponzio M, et al. An electrophysiological approach to the diagnosis of neurogenic dysphagia: implications for botulinum toxin treatment. J Neurol Neurosurg Psychiatry 2010;81:54-60.
6. Restivo DA, Marchese-Ragona R, Patti F, et al. Botulinum toxin improves dysphagia associated with multiple sclerosis. Eur J Neurol 2011;18:486-490.
7. Brooks BR El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis: Subcommittee on Motor Neuron Disease/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994;124(suppl):96-107.
8. Elidan J, Schochina M, Gonen B, Gay I. Manometry and electromyography of the pharyngeal muscles in patients with dysphagia. Arch Otolaryngol Head Neck Surg 1990;116:910-913.
9. Restivo DA, Solaro C, Maimone D, Pavone A, Marchese-Ragona R. Pharyngeal painful tonic spasms: paroxysmal painful swallowing. Ann Intern Med 2011;155:649-650.
10. Rosembek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration-aspiration scale. Dysphagia 1996;11:93-98.
11. Chiò A, Finocchiaro E, Meineri P, Bottacchi E, Schiffer D. Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS: Percutaneous Endoscopic Gastrostomy Study Group. Neurology 1999; 53:1123-1125.
12. Spataro R, Ficano L, Piccoli F, La Bella V. Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: effect on survival. J Neurol Sci 2011;304:44-48.
13. Mazzini L, Corrà T, Zaccala M, Mora G, Del Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 1995;242:695-698.
14. McKenna JA, Dedo HH. Cricopharyngeal myotomy: indications and technique. Ann Otol Rhinol Laryngol 1992;101:216-221.
15. Lebo CP, U KS, Norris FH Jr. Cricopharyngeal myotomy in amyotrophic lateral sclerosis. Laryngoscope 1976;86: 862-868.
16. Restivo DA, Lanza S, Marchese-Ragona R, Palmeri A. Improvement of masseter spasticity by botulinum toxin facilitates PEG placement in amyotrophic lateral sclerosis. Gastroenterology 2002;123:1749-1750.